We are expecting the UK Government to issue its Article 50 notice imminently.
The Life Sciences lawyers Charles Brasted, Elisabethann Wright, Fabien Roy, Helen Kimberley and Sahira Khwaja will discuss:
- What is the likely process from the serving of the Article 50 notice to the UK leaving the EU?
- What effect might Brexit have for existing and future marketing authorisations for medicinal products?
- How might medical device manufacturers be affected?
- How does the decision affect commercial contracts?
- What are the questions you should consider from an IP perspective?
- Is there anything you should do immediately?
- How can your businesses influence what happens next?
We look forward to having you join us.